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Abstract 
The establishment of the most stable structures of 2-(phenylmethyl)-2-
azaspiro[5.11]heptadecane-1,3,7-trione, potential anticancer and antimicrobial drug has been 
investigated in this work. A detailed interpretation of experimental and calculated IR, UV and 
NMR spectra were reported. The equilibrium geometry, harmonic vibrational frequencies and 
electronic properties have been investigated with Density Functional Theory using B3LYP/6-
311++G(d,p) method. The scaled theoretical wavenumber showed very good agreement with 
the experimental values. The charge transfer in the molecule was confirmed with NBO 
analysis. Ultraviolet–visible spectrum was calculated using TD-DFT method and compared 
with experimental spectrum. The calculated energy and oscillator strength well reproduce the 
experimental data. The molecular electrostatic potential surface map portrays potential 
binding sites of the title molecule. 
 
Keywords: 2-(phenylmethyl)-2-azaspiro[5.11]heptadecane-1,3,7-trione; Vibrational spectra; 
NMR spectra; NBO analysis; MEP;  
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1. Introduction 
Cyclic imides, especially five- and six-membered systems, are important group of bioactive 
molecules. They exhibit antitumor (sesbanimide [1], iso-migrastatin [2], lactimidomycin [3]), 
anti-inflammatory [4], immunomodulatory, antiangiogenic (thalidomide and analogues) [5], 
and anxiolytic (buspirone [6] and tandospirone [7]) activities.  
Isolation and examination of pharmacologicaly active natural glutarimides started in 
1960s. It was found that cycloheximide [8] and streptimidone [9,10,11] act as very potent 
cytotoxic agents [12,13]. Structurally related natural product lactimidomycin (LTM), 12-
membered unsaturated macrolide antibiotic, produced by Streptomyces amphibiosporus 
R310-104 (ATCC 53964), is characterized by a biosynthetically rare glutarimide side chain 
and display strong in vitro cytotoxicity against a number of human tumor cell lines, in vivo 
antitumor activity in mice model, and potent antifungal activity [2]. 
After extensive research controversial drug thalidomide (α-(N-
phthalimido)glutarimide) was approved as a drug for treatment of certain cancers (newly 
diagnosed multiple myeloma) and for complication arrised from leprosy as well as analogues 
of thalidomide with increased potency, 3-amino-thalidomid (pomalidomid, Pomalyst) and α-
(3-aminophthalimido)glutarimide (lenalidomid, Revlimid) have been developed [14,15]. 
Lenalidomid is used for treatment of multiple myeloma, while pomalidomid is recently 
approved by FDA for treatment of relapsed and refractory multiple myeloma.  
In the past decade, antitumor activity in vitro of mitonafide [16], amonafide [17], and 
naphthalimide [18] derivatives was intensively examined.  
In addition, glutarimides have applications in various other fields; for example, they 
are employed as polymers, activators and stabilizers, vulcanizing agents, lubricant additives, 
dyes and optical brightening agents, photographic and printing aids [19].  
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The most typical feature of glutarimide derivatives is that the pharmacological and 
spectroscopic properties can be readily modified by introduction of substituents in the 
glutarimide ring. Moreover, we are performing the synthesis and the properties relevant to 
antiproliferative and antibacterial activities of one series of glutarimide derivatives, with 
some newly synthesized compounds [20]. Cytotoxicity was tested toward three human cancer 
cell lines, HeLa, K562 and MDA-MB-453 by MTT assay. Compound 2-(phenylmethyl)-2-
azaspiro[5.11]heptadecane-1,3,7-trione (abbreviated as PAH), containing 12-membered 
ketone ring, was found to be the most potent toward all tested cell lines (IC50 = 9 to 27 µM). 
Also, minimum inhibitory concentration (MIC) determined by broth microdilution method 
confirmed that compound PAH inhibited the growth of all tested Gram-positive and some of 
the Gram-negative bacteria.  
In this paper we describe our results on 2-(phenylmethyl)-2-
azaspiro[5.11]heptadecane-1,3,7-trione (PAH) regarding the conformational, vibrational, 
electronic, NMR and reactivity analyses through spectral measurements. The vibrational 
spectra of PAH molecule have been analysed completely to identify the various normal 
modes with higher wavenumber accuracy. Density Functional Theory (DFT) B3LYP/6-
311++G(d,p) calculations have been performed to support our wavenumber assignments. The 
natural bond orbital (NBO) analysis has been done to prove the stabilization originating from 
the hyperconjugation of various intramolecular interactions. The UV-Vis spectroscopic 
studies along with frontier molecular orbital (FMO) analysis have been used to elucidate 
charge transfer through the molecule. Additionally, molecular electrostatic potential (MEP) 
surface is plotted over the optimised geometry to explain the reactivity and potential binding 
sites of PAH molecule. The calculated results were compared with the experimental and the 
observed spectra were analysed in detail. 
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2. Experimental Details  
Chemicals and solvents (analytical grade) were purchased from Merck (Darmstadt, 
Germany), Sigma-Aldrich and Fluka. All solvents were dried by standard methods and 
distilled before use. The sodium hydride was used as 60% dispersion in mineral oil. The 
reaction was monitored on silica gel precoated TLC plates, HF254 (Merck, Darmstadt, 
Germany). PAH was synthesised by tandem process described in our previous paper [21]. 
The process involved base-catalyzed Michael addition of active methylene compound to 
secondary acrylamide, followed by intramolecular N-acylation of the carboxamido group. 
PAH was synthesised in reaction of methyl-2-oxocyclododecane carboxylate (8.32 mmol), N-
benzylacrylamide (12.5 mmol), t-BuOK (0.47 g, 4.16 mmol) and 18-crown-6 ether (0.3 g, 
1.25 mmol) in a mixture of solvents THF/t-Pentanol (3:1). The reaction mixture was heated 
(70 °C, 3 h) and stirred under argon. Purification by dry-flash chromatography (SiO2, 
hexane/EtOAc) yielded PAH as white crystals in a yield of 55%. The synthesis of PAH is 
shown in Scheme S1, Supplementary material. 
The chemical structure and purity of the synthesised compound was confirmed by its 
melting point, 1H and 13C NMR, FT-IR, UV and ESI/HR-MS spectra. FT-IR spectrum was 
recorded with a Bomem MB 100 spectrophotometer. FT-IR spectrum of this compound was 
recorded in the region 400-4000 cm−1 at a resolution of 4 cm−1. The ultraviolet absorption 
spectrum of PAH was recorded from a 10−5 molar solution of PAH in chloroform and in the 
range 200-500 nm, using Shimadzu 1700 UV/Vis spectrophotometer. 1H and 13C NMR 
spectra were recorded in CDCl3 using TMS as an internal standard on a Bruker Avance 500 
spectrometer at 500 MHz and 125 MHz, respectively. ESI-MS spectra were recorded on 
Agilent Technologies 6210-1210 TOF-LC-ESI-HR/MS instrument. 
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3. Computational Details 
Initial calculations are shown that molecule of PAH can adopt two envelope conformations of 
glutarimide ring, two conformers accordingly to position of benzyl group and huge number of 
conformers for 12-membered ring. For generation of conformers for 12-membered ring the 
AMMP program [22] and Vega ZZ GUI [23] were used. The conformers are generated using 
the systematically conformational search and minimized with SP4 force field. Trajectories are 
analyzed, selected geometries are extracted with CatDCD, part of VMD program [24], and 
re-optimized with PM3 and B3LYP methods using Gaussian 09 program package [25]. All 
generated geometries are minimized without any constraint in the potential energy surface. 
The stability of the optimised geometries was confirmed by frequency calculations, which 
gave positive values for all the obtained frequencies. Optimised structural parameters were 
used in the vibrational frequency, electronic properties and isotropic chemical shift 
calculations.  
The assignments of the calculated wavenumbers were aided by the animation option 
of Gauss View 5.0 graphical interface from Gaussian programs. Furthermore, the theoretical 
vibrational spectra of the title compound are interpreted by means of Potential Energy 
Distribution (PED) using VEDA 4 program [26]. The harmonic frequencies were calculated 
with B3LYP/6-311++G(d,p) method and then scaled by 0.9604 [27] because the vibrational 
frequency values computed at this level contain known systematic errors [28]. The nuclear 
magnetic resonance (NMR) chemical shifts calculations were performed using Gauge- 
Independent Atomic Orbital (GIAO) method [29,30] at B3LYP level with 6-311++G(d,p) 
basis set and the 1H and 13C isotropic chemical shifts were referenced to the corresponding 
value for TMS, which was calculated at the same level of theory. The effect of solvent on the 
theoretical NMR parameters was included using conductor polarizable continuum model 
(CPCM) [31]. Chloroform (CHCl3) was used as solvent.  
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UV absorption spectrum of this compound was calculated by TD-DFT method in 
chloroform solvent. The FMO analysis of PAH was also calculated at the same level of 
theory. The NBO calculations were performed using NBO 3.1 program [32] as implemented 
in the Gaussian 09 package at the B3LYP/6-311++G(d,p) level. To portray the bonding sites 
and investigate chemical reactivity of the title molecule, MEP surface, for the 0.002 a.u. 
isosurfaces of electron density, is plotted over the optimized geometry of the most stable 
isomer I of PAH using Gauss View 5.0 program. 
 
4. Results and Discussion 
4.1. Conformational Stability 
The investigation of the most stable isomer of PAH, the challenging task in conformational 
analysis, has been studied. Also, the aim of the conformational analysis of the PAH molecule 
is to provide the best model for the molecular structure. 
Molecule of PAH can adopt four conformers according to glutarimide ring and 
position of benzyl group and huge number of conformations for 12-membered ring. For each 
of these four conformers the systematically conformational search was done changing the 
torsion angles around eleven C−C bonds of 12-membered ring for 120° followed by full 
minimization with SP4 force field. The one of the C−C bonds, which contains spiro C atom, 
is not included in systematically search to avoid a generation of huge number of unnatural 
conformers. To retain statistical probability of finding the all relevant conformers, the two 
searches were done with different C−C (spiro) bonds. The all generated trajectories are 
analyzed and ~5% of energetically most stable geometries of conformers are extracted and re-
optimized with PM3 method. All diverse conformers optimized with PM3 which do not differ 
in energy from the most stable one for more then 10 kcal/mol were additionally re-optimized 
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with B3LYP/6-31G(d) method. Then the full geometry optimizations of all unique structures 
were performed by B3LYP method with 6-311++G(d,p) basis set. 
As a result of these analyses conformer I have been obtained as energeticaly most 
stable one and it is shown in Figs 1 and 2. Fig. 1 also presents the geometries of the fifty 
stable conformers of PAH (I-L). The energies of these conformers as well as the relative 
energies and statistical Boltzmann distribution weighted values, are presented in Table S1 
(Supplementary material). From Fig. 1 it can be seen that conformer I have glutarimide ring 
in the envelope conformation with C4 atom under the plane of the glutarimide ring. This 
position of C4 atom is a prerequisite for the axial position of C3−C7 bond and at the same 
time the axial position of C7=O10 carbonyl group of cyclododecanone ring. Also, in this 
conformation, orientation of C7=O10 group is cis relative to the benzyl group, namely benzyl 
group is on the upper side of the plane of glutarimide ring. From Table S1 (Supplementary 
material), it can be concluded that the energy differences between conformers are low and 
therefore they can easily convert from one to another under the influence of external 
interactions.  
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Fig. 1. Superimposed molecular structures of the fifty most stable conformers of 2-
(phenylmethyl)-2-azaspiro[5.11]heptadecane-1,3,7-trione. The most stable conformer I is 
presented as tube structure. 
 
 
Fig. 2. Optimized molecular structure and atomic numbering of PAH (I). 
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In order to estimate the barrier height and confirm the transitions between conformers 
for the rotation around the C–C and N–C bonds potential energy curves are calculated using 
the B3LYP method with 6-31+G(d) basis set. The potential energy surface (PES) study has 
been carried out to confirm the orientation of benzyl group in PAH molecule. PES for the 
rotation of the benzyl group about N1–C21 bond was obtained for molecule I by calculating 
the variation of its total energy with change in the dihedral angle τ(C2–N1–C21–C22) 
between 0° and 360° in intervals of 5° by B3LYP/6-31+G(d) calculations. The PES scan for 
the position of benzyl group of PAH molecule is shown in Fig. 3. For this rotation two 
minima energy curve have been obtained at −86.13 and 88.83° (conformers I and II) as 
shown in Fig. 3 clearly demonstrates that the first minimum corresponds to the most stable 
conformer I. Thus, in its more stable configuration, the benzyl group is in cis orientation to 
the carbonyl group of cyclododecanone ring. It should be noted that the energy difference 
between these two structures is about 0.2 kcal/mol, which confirms that they can easily 
convert from one to another.  
 
 
Fig. 3. The potential energy curve of PAH along the C2–N1–C21–C22 dihedral angle. 
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Also, the PES scan for glutarimide part of investigated molecule is shown in Fig. 4. 
During the calculation all the geometrical parameters were simultaneously relaxed while the 
dihedral angles C3–C4–C5–C6 were varied form 60° to −80° by steps of 2.5°. Results of the 
geometry optimizations indicate that the title compound has two envelop conformers XI 
(−55°) and I (50°) for investigated dihedral angles, respectively. However, the latter is deeper 
than the former and represents the more stable conformation. The potential energy surface 
diagrams reveal that the conformation with minimum energy corresponds to the structure in 
which C4 atom lies under the plane of the glutarimide ring.  
 
 
Fig. 4. The potential energy curve of PAH along the C3–C4–C5–C6 dihedral angles. 
 
The PES scan for the dihedral angle C14–C15–C16–C17 of cyclododecanone part 
was varied form 0° to 360° by steps of 5°. For this rotation, four minima energy curve have 
been obtained as shown in Fig. 5. The energy difference between these structures is about 5 
kcal/mol and potential energy minimum at 67.4° corresponds to the most stable conformer I.  
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Fig. 5. The potential energy curve of PAH along the C14–C15–C16–C17 dihedral angle. 
 
4.2. Molecular Geometry 
The optimized geometrical parameters of conformer I of PAH calculated by B3LYP level 
with 6-311++G(d,p) basis set are listed in Table S2 (Supplementary material), the atom 
numbering scheme is given in Fig. 2. There is no X-ray crystal structure for this compound, 
so the calculated and experimental structural data have not been compared. 
4.3. Vibrational analysis 
The molecule PAH belongs to C1 point group and possesses 168 normal vibrational modes. 
The calculated frequencies are slightly higher than the experimental values for almost all of 
the normal modes. Two factors are responsible for this. The first is caused by the 
combination of electron correlation effects and basis set deficiencies and the second reason is 
the fact that the experimental value is an anharmonic frequency while the calculated value is 
a harmonic frequency. The theoretical harmonic wavenumbers have been scaled by the scale 
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factor of 0.9604 [27]. After implementing scaling procedure, the theoretically computed 
wavenumbers matched well with the experimental ones. For comparison, scaled theoretical 
and experimental FT-IR wavenumbers are presented in Table 1 along with vibrational 
assignments and calculated IR intensities. The experimental and calculated FT-IR spectra are 
shown in Fig. 6. The detailed assignments along with the percentage of PED are summarized 
in Table 1, the assignments having <10% (PED percentage) are not presented.  
 
 
Fig. 6. Comparison of experimental (top) and scaled theoretical IR spectra of PAH. 
 
Table 1. The observed and calculated vibrational frequencies using B3LYP/6-311++G(d,p) 
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method for PAH [harmonic frequency (cm−1), IRint (km mol−1)]. 
Mode 
no. 
IR exp 
cm-1 
Unscaled 
B3LYP 
Scaled 
B3LYP 
IR 
Intena 
Assignmentsb, 
PED (%) 
1 3086 3191 3064 9.77 νsymCH (94) 
2  3186 3060 10.94 νasyCH (93) 
3 3067 3180 3054 14.91 νasyCH (87) 
4  3169 3043 9.47 νasyCH (98) 
5  3160 3034 0.06 νasyCH (87) + νasyCH (11) 
6  3156 3031 0.31 νasyC21H2 (100) 
7 3054 3116 2993 9.67 νasyC4H2 (64) 
8  3115 2992 4.31 νasyC4H2 (81) 
9 3030 3106 2983 15.4 νasyC5H2 (64) 
10  3105 2982 1.82 νsymC21H2 (64) + νasyC5H2 (17) 
11 3003 3104 2981 14.03 νsymC21H2 (82) + νasyC5H2 (14) 
12 2981 3093 2971 45.45 νasyCH2 (15) + νasyCH2 (11) + νasyCH2 
(33) 
13  3091 2968 37.31 νasyCH2 (11) + νasyCH2 (51) 
14 2962 3074 2952 52.88 νasyCH2 (62) 
15 2941 3069 2947 87.73 νasyCH2 (74) 
16  3060 2939 32.15 νasyCH2 (62) 
17 2931 3056 2935 9.48 νsymC5H2 (51) + νsymC4H2 (19) 
18  3047 2926 9.47 νsymCH2 (41) + νsymCH2 (13) + νasyCH2 
(13) 
19  3046 2925 40.06 νasyCH2 (10) + νsymCH2 (55) 
20  3037 2917 9.97 νsymCH2 (79) 
21  3035 2915 22.3 νsymC4H2 (13) + νsymCH2 (40) 
22  3033 2913 33.55 νsymCH2 (77) 
23 2915 3033 2913 34.94 νsymCH2 (75) 
24  3030 2910 4.71 νsymC4H2 (16) + νsymCH2 (42) 
25  3028 2909 22.99 νsymCH2 (31) + νsymCH2 (39) 
26 2903 3027 2907 29.63 νsymCH2 (61) 
27  3025 2905 18.91 νsymCH2 (30) + νsymCH2 (13) + νsymCH2 
(11) + νsymCH2 (17) 
28 2866 3023 2903 21.4 νsymCH2 (82) 
29  3015 2895 8.39 νsymCH2 (77) 
30  3004 2885 28.52 νsymCH2 (83) 
31 2848 3003 2884 33.38 νsymCH2 (83) 
32 1725 1769 1699 149.44 νOC (74) 
33 1707 1753 1684 123.5 νOC (82) 
34 1673 1712 1644 401.9 νOC (79) 
35 1607 1644 1578 2.97 νCC (63) + βHCC (21) 
36 1561 1623 1559 3.56 νCC (70) 
37 1525 1526 1466 13.58 νCC (58) + βHCC (28) 
38 1496 1522 1461 25.87 δCH2 (67) 
39  1515 1455 0.46 δCH2 (59) 
40  1512 1452 0.32 δCH2 (10) + δCH2 (55) 
41 1467 1507 1448 1.41 δC4H2 (67) 
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42  1498 1439 3.64 δCH2 (61) + δCH2 (10) 
43  1494 1435 2.71 δCH2 (54) 
44  1492 1432 9.08 δCH2 (61) 
45  1488 1430 9.41 δCH2 (71) 
46  1487 1428 1.93 δCH2 (62) 
47  1486 1427 2.7 βHCH (44) + νCC (21) 
48 1457 1485 1426 13.12 δC5H2 (72) 
49  1484 1425 3.92 δCH2 (60) + δCH2 (11) 
50 1438 1473 1414 26.53 δC21H2 (85) 
51 1406 1470 1411 10.26 ωCH2 (83) 
52  1410 1354 0.17 ωCH2 (33) 
53  1407 1351 1.41 ωCH2 (41) + τHCCC (13) 
54 1382 1401 1346 29.47 ωC21H2 (59) 
55  1398 1343 0.99 ωCH2 (11) + τHCCC (42) 
56 1352 1390 1335 31.81 ω(C4H2+C5H2) (42) 
57  1387 1332 13.85 ωCH2 (48) 
58 1320 1381 1326 13.42 βHCC (18) + tC21H2 (13) 
59  1377 1323 0.5 ωCH2 (29) 
60  1376 1321 0.94 βHCC (16) + ωCH2 (22) 
61  1367 1312 5.47 ωCH2 (34) 
62  1364 1310 6.55 βHCC (35) + tC4H2 (14) + tC5H2 (14) 
63 1308 1355 1302 2.76 tCH2 (17) 
64  1353 1299 24.85 νCC (22) + βHCC (40) 
65 1294 1345 1292 2.91 βHCC (30) 
66  1338 1285 0.46 βHCC (13) + βHCC (18) + τHCCC (11) 
67  1331 1278 4.09 βHCC (35) 
68  1328 1275 156.91 νCC (14) + νNC (14) 
69 1281 1326 1273 105.32 νCC (30) + νNC (10) 
70  1322 1269 23.85 βHCC (10) + βHCC (19) 
71 1259 1308 1256 7.8 βHCC (11) 
72  1303 1251 4.33 βHCC (23) 
73  1292 1241 6.81 βHCC (19) + τHCCC (10) 
74 1248 1281 1231 3.36 t(C4H2+C5H2) (33) 
75  1270 1219 13.22 βHCC (18) + tCH2 (12) 
76 1235 1236 1187 3.32 tCH2 (28) 
77  1230 1181 8.6 βHCC (10) 
78  1221 1173 5.79 νCC (67) + βHCC (17) 
79 1203 1213 1165 13.22 tC5H2 (33) 
80 1181 1205 1157 3.22 νCC (20) + βHCC (73) 
81  1198 1150 2.64 βHCH (28) 
82 1164 1185 1138 73.52 νNC (12) + βHCC (15) 
83  1182 1135 2.63 βHCC (10) 
84 1142 1177 1130 167.06 νNC (24) 
85 1117 1152 1106 2.15 tCH2 (10) 
86  1127 1082 11.42 τHCCC (12) 
87  1120 1076 1.85 νCC (10) 
88 1080 1105 1061 66.84 νCC (13) + βHCC (24) + βCCC (18) 
89  1098 1055 0.14 νCC (60) 
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90  1096 1053 25.59 νCC (10) 
91 1049 1083 1040 11.61 νNC (10) 
92  1072 1030 1.5 νCC (43) 
93  1061 1019 1.75 νCC (10) 
94 1031 1056 1014 25.04 νCC (12) 
95 1013 1051 1009 8.68 βCCC (38) + νCC (14) + βHCC (16) + 
βCCC (18) 
96  1046 1005 2.56 νCC (22) 
97  1035 994 2.6 νCC (44) 
98 1004 1024 984 10.98 νCC (12) 
99  1018 978 0.08 νCC(42) + βCCC (45) 
100  1016 975 3.97 νCC (36) 
101  1006 966 2.6 γHCC (73) 
102 966 1003 963 52.76 νCC (19) 
103  994 955 0.98 γHCC (78) 
104 955 986 947 3.08 ρCH2 (10) 
105 942 965 927 15.31 ρCH2 (10) 
106 927 951 913 14.02 γHCC (15) + τHCNC (33) 
107  939 901 7.55 νCC (11) 
108  926 890 1.02 νCC (10) 
109 883 914 877 2.22 νNC (11) 
110 863 880 845 1.55 ρC5H2 (16) 
111 849 877 842 6.12 ρ(C4H2 + C21H2) (10) 
112  868 834 1.99 νCC (38) 
113 835 864 830 0.78 γHCC (97) 
114  839 806 7.46 ρCH2 (10) 
115 819 838 805 2.13 νCC (11) + νCC (17) + βCCN (15) + 
τHCCC (16) 
116  815 783 5.1 νCC (16) 
117 804 807 775 1.33 ρCH2 (27) 
118  795 763 1.85 νCC (22) 
119 744 772 742 13.61 γHCC (41) 
120 731 765 735 1.55 γOCNC (33) 
121  742 713 3.27 τHCCC (12) + τHCCC (10) 
122 708 731 702 18.06 ρCH2 (10) + ρCH2 (32) 
123  714 686 52.16 τHCCC (10) + τHCCC (31) + τHCCC 
(35) 
124  710 682 12.31 βCCC (10) + γOCCC (24) 
125  704 676 4.29 τHCCC (53) 
126 662 677 651 18.98 γOCCC (26) 
127 637 639 614 13.59 βCCN (10) + γOCCC (14) 
128  636 611 0.11 βCCC (85) 
129 621 616 591 7.06 νNC (10) + βCCO (10) 
130  610 586 17.04 βCCO (23) 
131 553 566 543 3.8 τHCCN (16) + γOCCC (17) 
132 531 537 516 3.79 νNC (16) + βCCO (16) + βCNC (15) 
133  523 503 1.91 βCCC (12) 
134 490 506 486 16.83 βCCO (21) + βCCC (12) 
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135 478 488 468 10.36 γCCC (12) + γCNC (15) + τCNCC 
136 465 471 452 3.25 γCCO (13) 
137 446 457 439 5.04 νNC (10) + βCCO (23) + βNCO (11) 
138 427 430 413 14.2 βCNC (44) + τHCCC (12) 
139  416 399 3.51 βCCC (21) 
140  415 399 0.51 γCCC (16) + τCCCC (71) 
141  405 389 13.3 βCCC (13) + βCCO (10) + βCNC (13) 
142  382 367 0.35 βCCC (11) + τCCCC (11) 
143  365 350 0.17 βCCC (11) + βCCC (15) 
144  339 326 0.47 γCCCC (10) 
145  316 303 4.12 γCCCO (16) 
146  300 288 6.32 γCNC (12) 
147  282 271 0.19 τCCCC (11) 
148  278 267 1.22 γCCCC (12) 
149  268 257 1.29 βCCC (21) + τHCCC (13) + τCCCC 
(22) 
150  254 244 0.5 νCC (24) + βCCC (25) 
151  250 240 1.57 βCCC (34) 
152  226 217 0.1 βCCC (36) + βCCC (11) 
153  216 208 0.76 βCCC (20) 
154  198 191 0.68 γCNC (25) 
155  184 177 2.76 τHCCC (15) + τCCCN (12) 
156  183 175 0.43 τCCCC (24) 
157  177 170 1.63 βCCC (10) + βCCC (11) + βCCC (12) 
158  160 154 5.34 τCCCC (15) + τCNCC (11) 
159  134 129 2.64 τCCCC (31) 
160  109 105 4.08 τCCCC (14) + τCCCN (13) 
161  95 91 0.92 τCCCC (26) 
162  82 79 1.83 τCCCC (11) 
163  73 70 0.33 βCCC (13) + τCCCC (19) 
164  62 59 0.36 γCCCC (26) 
165  41 40 0.49 βCCN (11) + τCCCN (11) + τCNCC 
(20) 
166  34 32 0.29 γCCCN (51) 
167  26 25 0.04 γCCCN (65) 
168  16 15 0.06 τCNCC (66) 
aIRInt – IR intensity; km mol−1; bPED less than 10% are not shown; ν – stretching; νsym 
symmetric stretching; νasy – asymmetric stretching; β – in plane bending; γ – out-of-plane 
bending; τ – torsion, ω – wagging; t – twisting; δ – scissoring; ρ – rocking; 
 
 
After scaling, correlation graph which presents the experimental (FT-IR) vs. 
calculated wavenumbers was drawn (Fig. S1, Supplementary material). The relation between 
these results is linear and described by the equation: 
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νcal. = 1.0012νexp. − 16.0386 (R2 = 0.9996) for B3LYP/6-311++G(d,p) 
 
Comparison of the wavenumbers calculated by the DFT/ B3LYP method using 6-
311++G(d,p) basis set with experimental values confirms that this method show good 
agreement with correlation coefficient 0.9996, Fig. S1 (Supplementary material).  
The investigated molecule consists of a glutarimide ring substituted with a 
cyclododecanone ring at position 3 and a benzyl group at position 1. Consequently, the 
vibrational modes are discussed in tree parts: vibrations of glutarimide ring, vibrations of 
benzyl group and vibrations of cyclododecanone group. 
4.3.1. Vibrations of Glutarimide Ring 
4.3.1.1. C=O group vibrations. It is well known in the literature that strongly polar bonds 
such as carbonyl groups produce very strong bands [33]. On the basis of PED, the prominent 
absorptions at 1673 and 1725 cm−1 in FT-IR are assigned to C2=O9 and C6=O8 stretching 
modes, respectively. The results of computations give the wavenumbers of these modes at 
1644 and 1699 cm−1. The region below 800 cm−1 is mostly dominated by in-plane and out-of-
plane ring vibrations. Also, the C–O in- and out-of-plane vibrations are expected in this 
region. The C=O in-plane bending modes are mixed with C–N stretching modes and in-plane 
bending modes of N–C–O group. The bands at 446, 490 and 621 cm−1 in FT-IR are assigned 
to C=O in-plane bending vibrations. The wavenumbers at 439, 486 and 591 cm−1 calculated 
by B3LYP/6-311++G(d,p) show excellent agreement with the experimental data. The C=O 
out-of-plane vibrations are coupled with out-of-plane ring vibrations and are observed in the 
region 160-300 cm−1 in calculated IR spectrum.  
4.3.1.2. C−N and C−C group vibrations. The identification of C–N vibrations is a difficult 
task, because of the mixing of bending and stretching bands in region of 1000-1500 cm−1. 
The C–N stretching absorptions assign in the region 1092-1401 cm−1 for substituted 
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piperidines [34]. In 1-(4-Chloro-phenyl)-3-phenyl-succinimide, the C–N stretching bands are 
found to be in the region 1024-1271 cm−1 [35]. In the present work, the FT-IR band observed 
at 1049, 1142, 1164 and 1281 cm−1 are assigned to C–N stretching mode. The theoretically 
calculated values of C–N stretching vibrations in the region 1040-1275 cm−1 (mode nos: 91, 
84, 82, 69 and 68) coincide with experimental data. The stretching vibration of N1–C21 bond 
toward benzyl group, assigned at 883 cm−1 (FT-IR) is in agreement with calculated frequency 
at 877 cm−1 (mode no: 109). The C–N–C in-plane bending vibration assigned at 531 cm−1 
(FT-IR) are in agreement with calculated frequencies by B3LYP/6-311++G(d,p) method at 
516 cm−1 (mode no: 132). The C–N–C out-of-plane bending vibration found at 478 cm−1 and 
correlate well with the computed value at 468 cm−1. 
The observed strong bands at 1004 and 1080 cm−1 in FT-IR are assigned to C−C 
stretching modes for glutarimide ring of PAH molecule. The wavenumbers at 984 and 1061 
cm−1 (mode nos: 98 and 88) calculated by B3LYP/6-311++G(d,p) show excellent agreement 
with the experimental data. Almost the C–C stretching vibrations are found overlapped with 
other vibrations and difficult to be assigned. Thus the C−C stretching mode 88 is coupled 
with in-plane bending C−H
 
and C−C vibrations. However, the mode 97 is pure mode and the 
PED contribution to this mode is 44%. The C−C−C bending modes are coupled with in-plane 
bending C−C−O vibrations for glutarimide ring. In FT-IR, band at 490 cm−1 is designated as 
C−C−C in-plane bending modes. The calculated counterparts belong to C−C−C in-plane 
vibrations are observed in the region 486-611 cm−1. In the present work, the calculated 
theoretical wavenumbers 267 and 326 cm−1 depicted in Table 1 are assigned as C−C−C out-
of-plane vibrations.  
4.3.1.3. C4H2 and C5H2 group vibrations. The C–H stretching vibrations of the methylene 
group are at lower frequencies than those of the aromatic C–H ring stretching. The 
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asymmetric CH2 stretching vibrations generally observed in the region is 3000-2900 cm−1, 
while the CH2 symmetric stretching vibrations are between 2900 and 2800 cm−1 [34]. 
The CH2 asymmetric and symmetric stretching vibrations of C4H2 and C5H2 group 
are observed in FT-IR spectrum as weak intensity bands as seen in Table 1 for our title 
molecule. The band at 2931 cm−1 in FT-IR spectrum is assigned to CH2 symmetric stretching 
vibrations, for both C4H2 and C5H2 groups. The theoretically computed wavenumbers for 
these groups are in the range 2910-2935cm−1 (mode nos. 24, 21 and 17). The weak intensity 
bands at 3030 and 3054 cm−1 in FT-IR spectrum are attributed to CH2 asymmetric stretching 
vibrations, for C5H2 and C4H2 group, respectively, as shown in Table 1 and correlate well 
with the calculated values at 2983 and 2993 cm−1, for C5H2 and C4H2 group, respectively.  
The fundamental bending CH2 vibrations of PAH appear in the frequency region 800-
1500 cm−1. These vibrations revealed to be mixed with C–C and C–N stretching as well as 
with C−C−C bending vibrations of glutarimide ring. In FT-IR spectrum of PAH, the weak 
bands at 1438-1496 cm−1 assigned to scissoring vibrations of CH2 groups. The theoretical 
wavenumber of CH2 scissoring vibrations 1426 and 1448 cm−1 (mode nos: 48 and 41) 
coincide very well with experimental values at 1457 and 1467 cm−1 for C5H2 and C4H2 unit, 
respectively. The FT-IR wagging mode at 1352 cm−1 corresponding to C5H2 and C4H2 units 
was calculated to be at 1335 cm−1 (mode no: 56). In the present work, the FT-IR frequencies 
observed in the range 1203-1248 cm−1 have been assigned to CH2 twisting vibrations. The 
theoretically computed values in the range 1165-1231 cm−1 (mode nos: 79, 76 and 74) show 
excellent agreement with experimental data. The CH2 rocking vibrations calculated to be 842 
and 845 cm−1 (mode nos: 111 and 110) are also in excellent agreement with recorded values 
at 849 and 863 cm−1.  
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4.3.2. Vibrations of benzyl group  
Vibrations of benzyl group are composed of phenyl group and C21H2 group vibrations.  
4.3.2.1. Vibrations of phenyl group. Aromatic C−H stretching vibrations generally occur in 
the region 3000-3100 cm−1 [35]. The theoretical description for this region is somewhat 
difficult due to the weakness of C−H stretching modes. For PAH, the C−H stretching 
aromatic ring vibrations predicted at 3034-3064 cm−1 for B3LYP/6-31++G(d,p) level of 
theory. These vibrations observed experimentally at 3067-3086 cm−1 in the FT-IR spectrum 
for PAH. The asymmetric stretching vibration of phenyl group is observed as low intense 
band at 3067 cm−1, while the symmetric stretching vibration is observed at 3086 cm−1 in the 
experimental spectra. The scaled theoretical values at B3LYP/6-311++G(d,p) of aromatic 
ring C−H stretching modes coincide well with that of experimental data as depicted in Table 
1. The percentage of PED predicts that C−H modes of PAH are very pure. The benzene ring 
C−H in-plane bending vibrations are usually medium and observed in the region 1035-1558 
cm−1, while the C−H out-of-plane bending vibrations lie in the region 702-928 cm−1 [35]. In-
plane C–H bending vibrations of phenyl group are observed in the range of 1164-1607 cm−1 
and out-of-plane bending vibrations at 744-927 cm−1 region, for PAH in the FT-IR spectrum. 
The in-plane C−H bending vibrations of phenyl group are observed as medium intense bands 
at 1164, 1181, 1320, 1525 and 1607 cm−1 in FT-IR and the corresponding calculated value 
are 1138, 1157, 1326, 1466 and 1578 cm−1. In-plane C–H bending vibration are also observed 
at 1173 and 1299 cm−1 in calculated IR spectrum which are mixed with stretching C−C 
vibrations of phenyl group. The weak IR bands at 744, 835 and 927 cm−1 are identified as 
C−H out-plane bends of phenyl ring and the corresponding calculated values are 742, 830 
and 913 cm−1. The theoretical wavenumbers of C–H in-plane and out-of-plane are well 
supported with those of the experimental ones.  
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The phenyl ring C–C stretching vibrations usually occur in the region 1421-1625 cm−1 [36]. 
The assignment of the skeletal C−C stretching modes in FT-IR is quite difficult, since these 
bands are masked by the more intense bands at 1200-1600 cm−1 originating from the CH2 
deformation vibrations. In the present work, phenyl ring C–C stretching vibrations are 
observed at 1281, 1525, 1561, and 1607 cm−1, in accordance with the computed values at 
1273, 1466, 1559 and 1578 cm−1 (mode nos: 69, 37, 36 and 35), respectively. In the present 
study, the bands observed at 1013 and 1080 cm−1 in FT-IR are assigned to ring in-plane 
bending modes for phenyl group, and the corresponding calculated values are 1009 and 1061 
cm−1 (mode nos: 95 and 88). The ring out-of-plane bending mode wavenumber is observed at 
478 cm−1 in FT-IR spectrum and correlate well with the corresponding calculated value at 
468 cm−1. 
4.3.2.2. C21H2 group vibrations. The methylene group C21H2 have two stretching and the 
couple of scissoring, wagging, rocking and twisting modes. The symmetric stretching band of 
this group is observed at 3003 cm−1 and correlated well with the theoretically scaled 
frequencies at 2981 and 2982 cm−1. The asymmetric stretching band of C21H2 group is 
calculated at 3031 cm−1. The CH2 scissoring mode generates band at 1438 cm−1 in FT-IR is 
matched well with predicted value at 1414 cm−1. The medium strong band at 1382 cm−1 in 
FT-IR is attributed to CH2 wagging and correlate well with calculated value at 1346 cm−1. 
For C21H2 group of the compound, the peaks at 849 and 1320 cm−1 in FT-IR are ascribed to 
rocking and twisting vibrations and the corresponding calculated values are 842 and 1326 
cm−1, respectively.  
4.3.3. Vibrations of cyclododecanone group 
4.3.3.1. C7=O10 group vibrations. The carbonyl stretching wavenumber of C7=O10 group 
of cyclododecanone ring of PAH is observed at 1707 cm−1. The results of computations give 
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the wavenumber of this mode at 1684 cm−1 (mode no. 33). Compared with the C6=O8 group, 
this group has lower stretching frequency (shift for 18 cm−1 to lower wavenumber), but it is 
underestimated to the stretching frequency of C2=O9. It is well known from the literature that 
the most intensive peak in the spectrum of cyclododecanone is the C=O stretching which is 
observed at 1713 cm−1 [37]. Also, the very strong intense bands observed in the region 1711-
1715 cm−1 can be assigned to C=O stretching vibrations in FT-IR spectra of derivatives of 
cyclododecanone [38]. The vibrational spectrum shows a medium intensive band around the 
600 cm−1. The C7–O10 in-plane deformations are observed at 490, 531 and 621 cm−1, 
respectively and these results are in according with calculated values at 486, 516 and 591 
cm−1. The out-of-plane deformation of this carbonyl group is observed at 465 cm−1 and 
calculated value is 452 cm−1. 
4.3.3.2. CH2 group vibrations. As can be seen from Table 1, there are two asymmetric and 
four symmetric CH2 stretching vibrations of aliphatic CH2 groups of cyclododecanone 
moiety. The asymmetric stretching bands of methylene hydrogens (CH2) are observed in 
region 2941-2981 cm−1. The corresponding calculated values are in the region 2939-2971 
cm−1. The symmetric stretching bands of methylene hydrogens are observed at 2848, 2866, 
2903 and 2915 cm−1 and correlate with the calculated values in the region 2884-2926 cm−1. 
The fundamental CH2 vibrations are able to scissoring, wagging, twisting and rocking appear 
in the frequency region 700–1400 cm−1 [39]. In title molecule, the scaled vibrational 
frequencies in the range of 1461-1428 cm−1 (mode nos. 38-46) are assigned to scissoring 
modes of methylene groups of cyclododecanone moiety are in good agreement with 
experimental value at 1496 cm−1. The CH2 wagging mode generate band 1406 cm−1and the 
scaled calculated wagging modes are in the range 1332-1411 cm−1, Table 1. Methylene 
twisting vibration (tCH2) of cyclododecanone ring has medium strong peak at 1235 cm−1 in 
FT-IR and is consistent with calculated values in the range 1187-1219 cm−1. Four bands 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 
24
assigned to the rocking vibrations of methylene units are observed at 708, 804, 942 and 955 
cm−1 and the calculated value are 702, 775, 927 and 947 cm−1. 
4.3.4. C–C–C Group Vibrations  
The C–C–C stretching vibrations of cyclododecanone ring predicted at 890-1076 cm−1 
correlate well with experimentally observed at 966, 1004, 1013, 1031 and 1080 cm−1. The 
observed frequency at 490 cm−1 belongs to the C–C–C in-plane bending mode and the 
appropriate calculated frequency is 486 cm−1 (mode no: 134). In the present work the C–C–C 
out-of-plane bending mode are calculate at 267 cm−1 (mode no: 148).  
4.4. Natural Bond Orbital Analysis 
The NBO analysis has been performed on PAH molecule in order to explain and confirm 
intramolecular charge transfer (ICT) and the electron density delocalization within the 
investigated molecule. The most significant interactions between ‘filled’ (donor) Lewis type 
NBO orbitals and ‘empty’ (acceptor) non Lewis NBO orbitals of PAH molecule are given in 
Table 2.  
 
Table 2. Second order perturbation theory analysis of Fock matrix in NBO basis. 
Donor 
NBO (i) 
Type ED (i) 
(e) 
Acceptor 
NBO (j) 
Type ED (j) 
(e)a 
E(2)b 
kcal/mol 
E(j)-E(i)c 
a.u. 
F(i,j)d 
a.u. 
N1-C2 σ 1.98615 N1-C6 σ* 0.09366 1.12 1.21 0.034 
N1-C2 σ  N1-C21 σ* 0.04163 1.01 1.12 0.03 
N1-C2 σ  C2-O9 σ* 0.01331 0.56 1.4 0.025 
N1-C2 σ  C3-C20 σ* 0.02287 0.75 1.17 0.027 
N1-C2 σ  C6-O8 σ* 0.01215 1.78 1.42 0.045 
N1-C6 σ 1.98613 N1-C2 σ* 0.08661 1.16 1.21 0.034 
N1-C6 σ  N1-C21 σ* 0.04163 0.97 1.11 0.03 
N1-C6 σ  C2-O9 σ* 0.01331 2.08 1.39 0.048 
C3-C20 σ 1.96225 C3-C7 σ* 0.08676 0.95 0.93 0.027 
C3-C20 σ  C7-O10 σ* 0.01446 0.95 1.2 0.03 
C3-C20 σ  C18-C19 σ* 0.01391 1.33 0.99 0.033 
C3-C20 σ  C19-C20 σ* 0.01511 0.57 0.99 0.021 
N1-C21 σ 1.97911 N1-C2 σ* 0.08661 1.08 1.12 0.032 
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N1-C21 σ  N1-C6 σ* 0.09366 0.91 1.11 0.029 
N1-C21 σ  C2-C3 σ* 0.06963 2.57 1.08 0.048 
N1-C21 σ  C5-C6 σ* 0.05321 2.09 1.11 0.043 
C22-C27 π 1.65538 C23-C24 π* 0.31852 20.41 0.28 0.068 
C22-C27 π  C25-C26 π* 0.33228 20.23 0.28 0.067 
C23-C24 π 1.65994 C22-C27 π* 0.34826 20.54 0.29 0.068 
C23-C24 π  C25-C26 π* 0.33228 20.78 0.28 0.068 
C25-C26 π 1.66437 C22-C27 π* 0.34826 20.49 0.29 0.069 
C25-C26 π  C23-C24 π* 0.31852 19.72 0.28 0.067 
N1 LP (1) 1.60913 C2-O9 π* 0.2328 49.67 0.27 0.109 
N1 LP (1)  C6-O8 π* 0.22184 46.83 0.28 0.107 
O8 LP (2) 1.86582 N1-C6 σ* 0.09366 27.84 0.66 0.122 
O8 LP (2)  C5-C6 σ* 0.05321 17.62 0.65 0.098 
O9 LP (2) 1.86776 N1-C2 σ* 0.08661 26.86 0.67 0.121 
O9 LP (2)  C2-C3 σ* 0.06963 18.77 0.63 0.099 
O10 LP (2) 1.87878 C3-C7 σ* 0.08676 22.59 0.61 0.106 
O10 LP (2)  C7-C11 σ* 0.06112 19.02 0.67 0.102 
aED, electron density. 
bE(2) means energy of hyperconjugative interactions. 
cEnergy difference between donor and acceptor i and j NBO orbitals. 
dF(i,j) is the Fock matrix element between i and j NBO orbitals. 
 
 
In PAH the intramolecular interactions are formed by the orbital overlap between 
bonding C–C, C–N and antibonding C–C, C–N and C–O orbitals which results in ICT 
causing stabilization of the PAH molecule. The intramolecular hyperconjugative interaction 
of the σ orbital of C–C and C–N bonds to the antibonding orbital of C–C and C–N bonds of 
the glutarimide ring leads to stabilization of the PAH molecule with the stabilisation energy 
in the range of 0.56–2.08 kcal/mol, as evident from Table 2. The intramolecular 
hyperconjugative interaction of σ(N1–C2) distribute to σ*(N1–C6, N1–C21, C3–C20, C6–O8 
and C2–O9) leads to stabilization of 0.56–1.78 kcal/mol. The same kind of interaction is 
calculated in the distribution from σ(N1–C6), to σ*(N1–C2, N1–C21 and C2–O9) with 
stabilization energy in the range of 0.97–2.08 kcal/mol. From Table 2 it can be concluded that 
the bonds in glutarimide ring have electron density of 1.986 e, demonstrating strong 
delocalization in this part of molecule. The highest σ electron delocalization originates from 
C2–C3, C5–C6 and N1–C2 bonds of the glutarimide ring with E(2) value in the range 1.16-
2.57 kcal/mol. The similar results of σ electron delocalization in cyclododecanone ring are 
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found around σ(C–C) bonds of this ring. NBO analysis obviously manifests the evidences of 
ICT from σ(C3–C20) to σ*(C3–C7, C7–O10, C18–C19 and C19–C20) orbitals with 
moderate stabilization energy of 0.57-1.33 kcal/mol, Table 2. Also the results of NBO 
analysis indicate that strong interaction exists between benzyl group and glutarimide ring. For 
example, the intramolecular hyperconjugative interaction of σ(N1–C21) distribute to σ*(N1–
C2, N1–C6, C2–C3 and C5–C6) leading to stabilization of 0.91-2.57 kcal/mol. 
The second order perturbation theory analysis of Fock matrix in NBO basis of PAH 
(Table 2) also points out intramolecular interaction due to the orbital overlap of π(C–C) and 
π*(C–C) of phenyl group, resulting in high electron density (approx. 0.335 e) of anti-bonding 
π orbitals (C–C).  
The interaction energy, related to the resonance in the molecule, is electron 
withdrawing to the ring through σ*of N1–C6 and C5–C6 bonds from the lone pair LP(2)O8 
which leads to stabilization energy of 27.84 and 17.62 kcal/mol, respectively. Also, the 
magnitude of charge transfer from the lone pairs of LP(2)O9 atom to anti-bonding σ orbitals 
C2–C3 and N1–C2 of glutarimide ring, amount to stabilization of 18.77 and 26.86 kcal/mol, 
while from LP(2)O10 to anti-bonding σ orbitals C7–C11 and C3–C7 of cyclododecanone 
ring is of 19.02 and 22.59 kcal/mol, respectively. The interaction energies of 
LP(1)N1 → π*(C2–O9) and LP(1)N1 → π*(C6–O8) are 49.67 and 46.83 kcal/mol, 
respectively. These results additionally confirm the existence of ICT in the investigated 
molecule. 
4.5. Electronic Properties 
The electronic absorption spectrum of the title compound in chloroform solvent was recorded 
within the 200–500 nm range and the representative spectrum of computed transitions plot on 
the experimental is shown in Fig. S2 (Supplementary material). The electronic absorption 
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spectrum of PAH was calculated by the TD-DFT on the B3LYP/6-311++G(d,p) level. The 
solvent effect was calculated with CPCM method [31]. The calculated vertical excitation 
energies, wavelength (λ), oscillator strength (f), composition of the most significant singlet 
excited states and experimentally obtained wavelengths are shown in Table 3.  
 
Table 3. Experimental and calculated absorption wavelength λ (nm), excitation energies E 
(eV), oscillator strengths (f) of the most significant singlet excited states for PAH calculated 
with B3LYP/6-311++G(d,p) method. 
Transition Experimental 
λ(nm) 
TD(DFT) method CHCl3 
λ (nm) Excitation energy E (eV) 
Oscillator 
strength f 
I 340 291.05 5.2599 (98→101) 0.0061 
II 285 239.57 5.1752 (100→102) 0.01 
III  234.07 5.2969 (96→101) 0.0227 
 
The structure of PAH allow σ–σ* and π–π* transition in the UV-Vis spectrum. NBO 
analysis indicates that most of molecular orbitals are σ type orbitals, so the electronic 
transitions are mainly derived from the contribution of σ–σ* bands. However, NBO analysis 
shows that the electronic transitions derived from π–π* orbitals are dominant and stronger 
(higher E(2) values, Table 2). The TD-DFT calculation predicts one low intense electronic 
transition at 291.05 nm with an oscillator strength f = 0.0061 which is in good agreement 
with the experimentally obtained maximum with λexp = 340 nm in chloroform, Fig. S2 
(Supplementary material). The first transition is between HOMO-2 (orbital 98) and LUMO 
(orbital 101). The next transition is HOMO (orbital 100) to LUMO+1 (orbital 102) at 239.57 
nm, with oscillation strength of 0.01 which correlates well with experimentally found peak at 
285 nm, Table 3. 
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The frontier orbitals, HOMO and LUMO illustrate the way the molecules interact 
with other species. Therefore, FMO analysis helps to elucidate the chemical reactivity of 
molecules.  
The lowest unoccupied molecular orbital is localized mainly on glutarimide ring and 
on the part C20–C3–C11 of cyclododecanone ring as shown in Fig. 7. The highest occupied 
molecular orbital is spread over the benzyl group, imide group of glutarimide ring and the 
carbonyl group C7=O10. The HOMO (orbital 100) to LUMO (orbital 101) transition implies 
an electron density transfer to the cyclododecanone ring from the benzyl and imide groups 
(π → π* transition) and from the lone pair on nitrogen and oxygen atoms (n → π* transition). 
The HOMO laying at −6.97311 eV and the LUMO laying at −1.45873 eV (computed by TD-
DFT) and the energy gap is 5.51 eV. 
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Fig. 7. The frontier molecular orbitals (HOMO and LUMO) for PAH. 
 
4.6. NMR Analysis 
It is well known that chemical shifts of hydrogen and carbon atoms in NMR spectra contain 
information about the molecular structure. Also, the chemical shifts show sensitivity 
according to conformational variations. The combination of experimental and computational 
NMR spectra is used to prove the structure of the most stable isomer of PAH molecule. The 
experimental NMR spectra of PAH were recorded in CDCl3 and shown in Figs S3 and S4 
(Supplementary material). The experimental and theoretical values for 1H and 13C NMR 
shifts of PAH are presented in Tables 4 and 5.  
 
Table 4. Theoretical and experimental 1H NMR chemical shifts of PAH compound in CDCl3 
solution (atom positions were numbered as in Fig. 2). 
Hydrogen B3LYP/6311++G(d,p) Experimental 
28  H 1.94 1.97 
29  H 0.90 0.91 
30  H 3.18 3.19 
31  H 1.04 1.19 
32  H 1.11 1.33 
33  H 1.20 1.51 
34  H 1.04 1.19 
35  H 1.38 1.58 
36  H 1.28 1.52 
37  H 1.36 1.56 
38  H 1.16 1.31 
39  H 1.20 1.50 
40  H 1.31 1.53 
41  H 1.34 1.54 
42  H 1.37 1.57 
43  H 1.28 1.53 
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44  H 1.13 1.50 
45  H 0.94 0.94 
46  H 2.58 1.59 
47  H 1.32 1.54 
48  H 1.52 2.59 
49  H 2.53 2.56 
50  H 2.67 2.69 
51  H 2.66 2.67 
52  H 5.52 5.01 
53  H 4.50 4.91 
54  H 7.72 7.34 
55  H 7.43 7.22 
56  H 7.57 7.27 
57  H 7.57 7.22 
58  H 7.82 7.34 
 
Table 5. Theoretical and experimental 13C NMR chemical shifts of PAH compound in CDCl3 
solution (atom positions were numbered as in Fig. 2). 
Carbon B3LYP/6-311++G(d,p) Experimental 
2  C 182.53 171.9 
3  C 68.24 59.96 
4  C 28.82 23.26 
5  C 35.71 29.94 
6  C 183.35 172.68 
7  C 219.09 204.81 
11  C 40.29 34.66 
12  C 26.33 21.99 
13  C 27.01 23.07 
14  C 26.63 22.4 
15  C 31.93 26.26 
16  C 26.19 21.66 
17  C 24.93 21.21 
18  C 31.41 26.21 
19  C 22.80 18.78 
20  C 39.14 33.81 
21  C 48.33 43.39 
22  C 146.99 136.92 
23  C 136.45 128.81 
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24  C 135.48 128.4 
25  C 134.10 127.52 
26  C 134.86 128.4 
27  C 138.54 128.81 
 
In experimental 1H NMR spectrum of PAH, shifts of aliphatic C-H protons are 
occurred in the range of 0.91-5.91 ppm and the calculated are in the range 0.90-5.52 ppm. 
There are many differences in the chemical shifts in the aliphatic region of this spectrum. For 
example, the chemical shift of hydrogen attached to carbon near the carbonyl group is higher 
than one that would be expected regarding the electron density around the hydrogen. The 
hydrogen atom of C11−H30 group appears at higher chemical shift of 3.19 ppm due to 
influence of carbonyl group C7=O10 with theoretical peak at 3.18 ppm. The same applies for 
the hydrogens bonded to C20 (H46 and H47) appear at 1.59 and 1.54 ppm due to influence of 
carbonyl group C2=O9. Two multiple signals appearing at 2.56, 2.59 and 2.67, 2.69 ppm are 
assigned to protons (H49, H48 and H51, H50) of two methylene groups in glutarimide ring, 
C4H2 and C5H2 of PAH (Table 4). These signals show good agreement with theoretical 
values in the region 1.52-2.67 ppm. Two doublets of doublets at 4.91 and 5.01 ppm (in 
CDCl3 solution) mark the methylene hydrogens H53 and H52 of methylene group C21H2. 
The calculated chemical shift values for these hydrogen atoms (with respect to TMS) are 4.5 
and 5.52 ppm in CDCl3 solution. The calculated chemical shift values for phenyl ring 
hydrogens are at 7.43-7.82 ppm and experimental peaks for these atoms are in the range of 
7.22-7.34 ppm. 
Chemical shifts of the carbon atoms in 13C NMR spectra of PAH do not show 
unexpected values. In the experimental 13C NMR spectrum, carbon atoms of methylene 
groups of cyclododecanone ring show signals in the range of 18.78-34.66 ppm and correlate 
very well with the computed values in the range of 22.8-40.29 ppm, Table 5. The methylene 
carbon atoms of glutarimide ring C4 and C5 appear at 23.26 and 29.94 ppm, and calculated 
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values are 28.82 and 35.71 ppm. Spiro carbon atom C3 is observed at 59.96 ppm, whereas the 
corresponding computed value is 68.24 ppm. Signals for aromatic carbons are observed in the 
range 127.52-136.92 ppm for the phenyl ring of PAH. The carbonyl atoms C2, C6 and C7 
resonating at 171.9, 172.68 and 204.81 ppm and computed values are 182.53, 183.35 and 
219.09 ppm. 
4.7. Molecular Electrostatic Potential (MEP) 
Considering the great anticancer activity of PAH molecule, it was necessary to find the 
molecular fragments that are responsible for this activity as well as for chemical reactivity. 
The analysis of molecular electrostatic potential could predict those parts of molecule 
responsible for the electrophilic and nucleophilic reactions as well as inter- and/or intra-
molecular bonds. The MEP at the B3LYP/6-311++G(d,p) optimized geometry was calculated 
and depicted in Fig. 8. The negative regions of the MEP are related to electrophilic reactivity 
and are colored in red and yellow. The positive, blue regions are related to nucleophilic 
reactivity, Fig. 8. As can be seen from the figure, negative region is localized over the N and 
O atoms. The maximum positive region, dark blue, is localized on the C−H bonds of 
glutarimide ring. This region gives information about possible sites for nucleophilic attack. 
According to these calculated results, the MEP map shows that the negative sites are on 
electronegative nitrogen atom of the imide group and oxygen atoms of carbonyl groups. The 
positive sites are around the hydrogen atoms of glutarimide ring.  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 
33
 
Fig. 8. MEP of investigated molecule calculated with B3LYP/6-311++G(d,p) method. 
 
5. Conclusion 
The conformational stability of PAH is thoroughly studied and results are presented in this 
paper. The most stable conformer of the glutarimide spiro derivative PAH was found and its 
spectroscopic properties were investigated experimentally and with the help of DFT. The 
most stable conformer I has cis orientation of benzyl group and carbonyl group of 
cyclododecanone ring. The coformational, vibrational, electronic and NMR analyses were 
done with B3LYP/6-311++G(d,p) method. In addition, NBO analysis has provided evidence 
of the ICT through the molecule. The MEP map anticipates that imide fragment (oxygen and 
nitrogen atoms) of PAH is the most reactive site for electrophilic and hydrogen atoms of 
methylene groups of glutarimide ring for nucleophilic attack. 
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Structural and Vibrational Analyses of New Potential Anticancer Drug 
2-(phenylmethyl)-2-azaspiro[5.11]heptadecane-1,3,7-trione 
 
 
► Conformational analysis of PAH has been computed by B3LYP method. 
 
► FT-IR, UV–vis and NMR spectra of PAH are compared with calculated 
data. 
 
► The IR bands are assigned using PED analysis 
 
► The ICT was elucidated by NBO and FMO analyses.  
 
► MEP analysis was also performed.  
 
